<SEC-DOCUMENT>0001137774-25-000078.txt : 20250515
<SEC-HEADER>0001137774-25-000078.hdr.sgml : 20250515
<ACCEPTANCE-DATETIME>20250515174118
ACCESSION NUMBER:		0001137774-25-000078
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250515
DATE AS OF CHANGE:		20250515

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Arcutis Biotherapeutics, Inc.
		CENTRAL INDEX KEY:			0001787306
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				812974255
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-91349
		FILM NUMBER:		25956142

	BUSINESS ADDRESS:	
		STREET 1:		3027 TOWNSGATE ROAD
		STREET 2:		SUITE 300
		CITY:			WESTLAKE VILLAGE
		STATE:			CA
		ZIP:			91361
		BUSINESS PHONE:		805-418-5006

	MAIL ADDRESS:	
		STREET 1:		3027 TOWNSGATE ROAD
		STREET 2:		SUITE 300
		CITY:			WESTLAKE VILLAGE
		STATE:			CA
		ZIP:			91361

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Arcutis, Inc.
		DATE OF NAME CHANGE:	20190905

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PRUDENTIAL FINANCIAL INC
		CENTRAL INDEX KEY:			0001137774
		STANDARD INDUSTRIAL CLASSIFICATION:	LIFE INSURANCE [6311]
		ORGANIZATION NAME:           	02 Finance
		EIN:				223703799
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		751 BROAD ST
		CITY:			NEWARK
		STATE:			NJ
		ZIP:			07102
		BUSINESS PHONE:		9738026000

	MAIL ADDRESS:	
		STREET 1:		751 BROAD ST
		CITY:			NEWARK
		STATE:			NJ
		ZIP:			07102
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <previousAccessionNumber>0001137774-24-000039</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001137774</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>2</amendmentNo>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>03/31/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001787306</issuerCik>
        <issuerName>Arcutis Biotherapeutics, Inc.</issuerName>
        <issuerCusip>03969K108</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>3027 TOWNSGATE ROAD</com:street1>
          <com:street2>SUITE 300</com:street2>
          <com:city>WESTLAKE VILLAGE</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>91361</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(b)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>PRUDENTIAL FINANCIAL INC</reportingPersonName>
      <citizenshipOrOrganization>NJ</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>198527.00</soleVotingPower>
        <sharedVotingPower>11755543.00</sharedVotingPower>
        <soleDispositivePower>198527.00</soleDispositivePower>
        <sharedDispositivePower>11755543.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>11954070.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>10.1</classPercent>
      <typeOfReportingPerson>HC</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Arcutis Biotherapeutics, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CALIFORNIA, 91361.</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName> Prudential Financial, Inc.</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>751 Broad Street
Newark, New Jersey 07102-3777
</principalBusinessOfficeOrResidenceAddress>
        <citizenship>New Jersey</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>N</notApplicableFlag>
        <typeOfPersonFiling>HC</typeOfPersonFiling>
      </item3>
      <item4>
        <amountBeneficiallyOwned>11,954,070</amountBeneficiallyOwned>
        <classPercent>10.1</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>198,527</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>11,755,543</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>198,527</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>11,755,543</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>N</notApplicableFlag>
        <ownershipMoreThan5PercentOnBehalfOfAnotherPerson>Our clients may have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities which are the subject of this filing.</ownershipMoreThan5PercentOnBehalfOfAnotherPerson>
      </item6>
      <item7>
        <notApplicableFlag>N</notApplicableFlag>
        <subsidiaryIdentificationAndClassification>Prudential Financial, Inc. is a Parent Holding Company and the indirect parent of the following subsidiaries, who are the beneficial owners of the number and percentage of securities which are the subject of this filing as set forth next to their names:

Subsidiaries 	 	                                                                      Number of shares 	Percentage
Jennison Associates LLC                                        IA                           11,360,875               9.6
PGIM, Inc.                                                               IA                            585,000                   0.5
PGIM Quantitative Solutions LLC                           IA                            8,195                       0.0
</subsidiaryIdentificationAndClassification>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under &amp;#167; 240.14a-11.

</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>PRUDENTIAL FINANCIAL INC</reportingPersonName>
      <signatureDetails>
        <signature>RICHARD BAKER</signature>
        <title>SECOND VICE PRESIDENT</title>
        <date>05/15/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
